A carregar...
Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability
Increased rates of tuberculosis (TB) reactivation have been reported in humans treated with tumor necrosis factor-α (TNF)-neutralizing drugs, and higher rates are observed with anti-TNF antibodies (e.g. infliximab) as compared with TNF receptor fusion protein (etanercept). Mechanisms driving differe...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3311778/ https://ncbi.nlm.nih.gov/pubmed/22379032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1103298 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|